CIK 0000014272 · Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 220790350
- Phone
- 6092524621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-30 | Arduini Peter J Director | Grant or award · Deferred Share Units | +729.1 | 62,988.87 | ||
| 2025-06-30 | McMullen Michael R. Director | Grant or award · Deferred Share Units | +728.36 | 9,171.66 | ||
| 2025-06-30 | Rice Derica W Director | Grant or award · Deferred Share Units | +810.11 | 32,497.26 | ||
| 2025-06-30 | Samuels Theodore R. II Director | Grant or award · Deferred Share Units | +1,080.15 | 59,477.23 | ||
| 2025-06-30 | YALE PHYLLIS R Director | Grant or award · Deferred Share Units | +756.1 | 36,447.72 | ||
| 2025-06-13 | BOERNER CHRISTOPHER S. Chief Executive Officer | Gift | −62,719 | 0 | ||
| 2025-06-13 | BOERNER CHRISTOPHER S. Chief Executive Officer | Gift | +62,719 | 125,439 | ||
| 2025-06-03 | Short Bartie Wendy EVP, Corporate Affairs | Option exercise | +8,040 | 8,040 | ||
| 2025-06-03 | Short Bartie Wendy EVP, Corporate Affairs | Shares withheld for taxes | −3,334 | $48.09 | $160K | 4,706 |
| 2025-06-03 | Short Bartie Wendy EVP, Corporate Affairs | Option exercise · Restricted Stock Units | −8,040 | 16,080 | ||
| 2025-06-03 | BOERNER CHRISTOPHER S. Chief Executive Officer | Gift | −62,720 | 62,719 | ||
| 2025-06-03 | BOERNER CHRISTOPHER S. Chief Executive Officer | Gift | +62,720 | 62,720 | ||
| 2025-05-09 | Hickey Benjamin President, RayzeBio Org. | Sale | −97.39 | $38.01 | $4K | 0 |
| 2025-05-01 | Lenkowsky Adam EVP, Chief Commercial Officer | Other disposition · Market Share Units | −1,373 | 2,748 | ||
| 2025-04-25 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Purchase | +4,250 | $47.58 | $202K | 83,513.49 |
| 2025-04-01 | Shanahan Karin EVP, Glob. Prod. Dev. & Supply | Option exercise | +3,306 | 15,489 | ||
| 2025-04-01 | Shanahan Karin EVP, Glob. Prod. Dev. & Supply | Shares withheld for taxes | −1,692 | $59.55 | $101K | 13,797 |
| 2025-04-01 | Shanahan Karin EVP, Glob. Prod. Dev. & Supply | Option exercise · Restricted Stock Units | −3,306 | 3,307 | ||
| 2025-03-31 | YALE PHYLLIS R Director | Grant or award · Deferred Share Units | +573.87 | $60.99 | $35K | 35,251.07 |
| 2025-03-31 | Samuels Theodore R. II Director | Grant or award · Deferred Share Units | +819.81 | $60.99 | $50K | 57,676.27 |
Page 15 of 40 · 799 trades